IRIS - Res&Arch Institutional Research Information System - Research & Archive

GIANNANTONI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.694
EU - Europa 14.829
AS - Asia 9.808
SA - Sud America 1.898
Continente sconosciuto - Info sul continente non disponibili 739
AF - Africa 289
OC - Oceania 16
Totale 44.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.253
SG - Singapore 4.493
IT - Italia 3.172
UA - Ucraina 2.952
SE - Svezia 1.935
IE - Irlanda 1.834
RU - Federazione Russa 1.627
BR - Brasile 1.439
CN - Cina 1.265
HK - Hong Kong 1.123
VN - Vietnam 955
DE - Germania 801
FR - Francia 749
FI - Finlandia 649
KR - Corea 567
GB - Regno Unito 420
CA - Canada 249
BD - Bangladesh 218
IN - India 209
TR - Turchia 171
AR - Argentina 142
IQ - Iraq 124
NL - Olanda 111
PK - Pakistan 109
CH - Svizzera 100
CO - Colombia 95
BE - Belgio 88
PL - Polonia 87
UZ - Uzbekistan 84
MX - Messico 80
EC - Ecuador 74
ID - Indonesia 68
MA - Marocco 68
SA - Arabia Saudita 64
JP - Giappone 63
ZA - Sudafrica 63
AT - Austria 60
VE - Venezuela 58
ES - Italia 49
PH - Filippine 43
LB - Libano 38
EU - Europa 36
EG - Egitto 32
MY - Malesia 31
RO - Romania 29
PY - Paraguay 27
CL - Cile 26
CZ - Repubblica Ceca 26
GR - Grecia 24
TN - Tunisia 24
JO - Giordania 23
NP - Nepal 23
CR - Costa Rica 21
JM - Giamaica 19
LT - Lituania 17
ET - Etiopia 16
KE - Kenya 16
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
DZ - Algeria 14
IL - Israele 14
UY - Uruguay 14
AU - Australia 12
IR - Iran 12
RS - Serbia 12
AZ - Azerbaigian 11
HN - Honduras 11
NI - Nicaragua 11
AL - Albania 10
BO - Bolivia 10
KG - Kirghizistan 10
KZ - Kazakistan 10
PE - Perù 10
PS - Palestinian Territory 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
PA - Panama 8
PT - Portogallo 8
BB - Barbados 7
TH - Thailandia 7
CI - Costa d'Avorio 6
NO - Norvegia 6
OM - Oman 6
AO - Angola 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HU - Ungheria 5
LU - Lussemburgo 5
MK - Macedonia 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BZ - Belize 4
DK - Danimarca 4
EE - Estonia 4
GA - Gabon 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
BF - Burkina Faso 3
Totale 43.479
Salva come PNG Salva come JPEG
Città #
Singapore 3.053
Chandler 2.468
Dublin 1.831
Jacksonville 1.477
San Mateo 1.218
Hong Kong 1.114
Boardman 823
San Jose 818
Ashburn 790
Santa Clara 621
Seoul 558
Medford 516
Princeton 507
Moscow 491
Dong Ket 467
Lauterbourg 431
Wilmington 402
Andover 322
Ann Arbor 289
Des Moines 263
Piscataway 259
Altamura 246
Beijing 232
Milan 225
New York 215
Ho Chi Minh City 198
Los Angeles 185
Lawrence 180
Rome 171
Shanghai 157
Saint Petersburg 143
Munich 131
Perugia 131
Ottawa 103
São Paulo 103
Hanoi 101
Helsinki 97
The Dalles 91
Norwalk 90
Turin 90
Brussels 86
Izmir 76
Woodbridge 71
Orem 68
Frankfurt am Main 67
Dallas 64
Columbus 60
Chicago 58
Tokyo 56
Turku 55
Phoenix 54
Falls Church 53
Baghdad 51
Houston 49
Montreal 47
Redwood City 45
Auburn Hills 44
Belo Horizonte 44
Chennai 43
Toronto 41
Florence 40
Rio de Janeiro 39
Bologna 38
Warsaw 38
Buffalo 37
Naples 37
Tashkent 37
Council Bluffs 36
Atlanta 34
Bogotá 31
Islamabad 31
Stockholm 31
Brooklyn 30
Denver 28
Ouezzane 28
Curitiba 26
Genoa 26
Nuremberg 26
Dhaka 25
Medellín 25
Philadelphia 25
Redmond 25
San Paolo di Civitate 25
Amsterdam 24
Guayaquil 24
Istanbul 24
Johannesburg 24
Lahore 24
Lausanne 24
Boston 23
Dearborn 23
Jeddah 23
London 23
Manchester 23
San Francisco 23
Den Haag 22
Mondolfo 22
Scandiano 22
Napoli 21
Riyadh 20
Totale 23.846
Salva come PNG Salva come JPEG
Nome #
BCG vs Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio. Studio prospettico randomizzato. 1.786
1 hour pad test ha un basso valore predittivo nella diagnosi dell’incontinenza urinaria femminile 419
Sacropessia e colposospensione secondo Burch per il trattamento del prolasso genitourinario associato ad incontinenza urinaria: risultati preliminari di uno studio prospettico randomizzato 343
DIAGNOSI ECOGRAFICA DI DEFICIT SFINTERICO URETRALE NELLA DONNA 267
1-hour pad test has low predictive value in the diagnosis of women with urinary incontinence 243
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 223
Il Pad test di un’ora nella valutazione dell’incontinenza urinaria femminile 180
Abdominal integral pelvic reconstruction plus or minus Burch colposuspension in the treatment of severe uro-genital prolapse associated to urinary incontinence. A RCT with a mid-term follow up 180
Abdominal surgery for uterovaginal prolapse: sacropexy vs hysterocolposacropexy 173
Stability of Resiniferatoxin stock solutions 171
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 170
Intraprostatic Botox injection in patients with severe benign prostatic hyperplasia. 159
Analisi della funzione vescicale in soggetti con diabete mellito di tipo 1. Risultati preliminari - Atti del Congresso Nazionale SID 153
RUOLO DELLA COLPOSACROPESSIA LAPAROSCOPICA NELLA CORREZIONE DEL PROLASSO UROGENITALE RECIDIVO DOPO FALLIMENTO DI CHIRURGIA TRANVAGINALE CON MESH 145
Performance of incontinence impact questionnaire (IIQ) in italian population according to educational status 145
A personal surgical experience with orthotopic ileal neo-bladder reconstruction: long term functional results 140
INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOXINA IN PAZIENTI AFFETTI DA SINDROME DELLA VESCICA IPERATTIVA: BEST- PRACTICE MANAGEMENT 139
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study 138
IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity. 138
Il pad test di un’ora nella valutazione dell’incontinenza urinaria femminile 137
Body Mass Index e sintomatologia urinaria nella donna 137
Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. 136
Effects of Botulinum-A toxin intravesical injections on bladder hypersensitive disorders: a pilot study 133
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up”. 132
"Advanced analysis in the pressure flow-study: a comparison of methods". 132
Efficacia e tollerabilità della Solifenacina Succinato nella terapia della vescica iperattiva: risultati a breve termine 131
ONABOTULINUMTOXIN A INTRADETRUSOR INJECTIONS IN THE TREATMENT OF REFRACTORY DETRUSOR OVERACTIVITY DUE TO PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY 130
Colposuspension during sacropexy as a prophylaxis for post-operative urinary stress incontinence 129
Chirurgia conservativa reiterata nella neoplasia renale plurirecidiva 129
Master di II livello in uroginecologia: quali i risultati chirurgici 128
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 128
Bladder and urethral sphincter function after radical prostatectomy: long term follow up. 126
Intravesical resiniferatoxin versus botulinum A toxin injections for the treatment of neurogenic detrusor overactivity 126
SEXUAL DYSFUNCTION IN PATIENTS WITH MULTIPLE SCLEROSIS: PREVALENCE AND IMPACT OF SYMPTOMATIC TREATMENTS 126
Efficacy and tolerability of solifenacin 5 mg once daily in the treatment of OAB sindrome 125
Il Q-tip test vs ecografia nella diagnosi di ipermobilità uretrale: nostra esperienza 123
Qualità della vita dopo prostatectomia radicale retropubica o radioterapia esterna nel carcinoma prostatico clinicamente localizzato. 122
Valsalva Leak Point Pressure measurement: reliability of current procedures in the classification of stress urinary incontinence 121
Clinical and surgical predictors of urinary incontinence after radical retropubic prostatectomy. 120
Determinazione dei livelli vescicali tissutali di isoprostano 8-epi-PGF2 alfa in pazienti con disfunzioni vescico-sfinteriche ad elevato stress ossidativo 119
ANALISI DI VARIABILI PSICOLOGICHE IN PAZIENTI CON SINDROME DEL DOLORE PELVICO CRONICO. 119
Uterus preservation vs hysterectomy during sacropexy 119
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 118
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a psospective randomized study 118
La colposospensione associata a Ricostruzione integrale del pavimento pelvico. 118
Utilizzo degli Alfa-litici nelle donne con sintomi del basso tratto urinario 116
The potential and promise of using botulinum toxin in the prostate gland. 116
"In reply to Dr Silver" 115
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 115
Sequential Bacillus Calmette Guerin and electromotive mitomycin-C versus Bacillus Calmette Guerin alone for high-risk superficial bladder cancer: a prospective controlled study. 115
Prostasomi e carcinoma prostatico. 114
Sindrome depressiva e incontinenza urinaria 114
Botulinum a toxin intravesical injections for painful bladder syndrome: impact upon pain, psychological functioning and quality of life 114
Sacropexy with uterine conservation: results after 5 years 114
Botulinum A toxin modulates afferent fibers in neurogenic detrusor overactivity 113
Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results. 113
"Psychological investigation and sexual dysfunction in spinal cord injury women". 112
Alpha lithic agents for women with lower urinary tract symptoms. 112
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 112
Il ruolo del MUCP e del VLPP preoperatori nel predirre i risultati delle pazienti sottoposte a TOT 111
Urological dysfunction and upper urinary tract involvement in Multiple Sclerosis patients 111
Correlation between bladder echography and urodynamic examination in patients with multiple sclerosis 111
Prostasomes and prostate cancer. 111
Botulinum toxin Type-A activity in prostate cancer 111
Autonomic dysreflexia during urodynamics 111
BCG intravescicale versus Mitomicina C per diffusione passiva o elettrostimolata in pazienti con carcinoma in situ della vescica: studio randomizzato. 110
A prospective randomised trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence 110
Somministrazione intravescicale sequenziale di Bacillus di Calmette-Guerin e Mitomicina C elettrostimolata nei tumori superficiali della vescica ad alto rischio: studio prospettico controllato. 110
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 110
Bladder and urethral sphincter function after radical retropubic prostectomy: 3 years follow up. 109
Is isoprostane 8-iso-PGF2a a reliable marker of different velico-sphincter dysfunction? 109
Prostasomi e carcinoma prostatico. 109
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study 109
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 109
Iniezione intravescicale di tossina botulinica A nel trattamento della vescica ipersensibile 109
Female sexual dysfunction in urogenital prolapse surgery: colposacropexy vs hysterocolposacropexy 108
OVERACTIVE BLADDER, URINARY INCONTINENCE AND DEPRESSION 108
Valsalva leak point pressure and the role of pelvic floor muscles 107
PUMA vs Romanzi in the detection of female bladder obstruction and detrusor contractility 107
Tension-free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial 107
Bladder and urethral sphincter function after radical retropubic prostatectomy: a 3 year follow up. 107
Voiding dysfunction in spinal cord lesions of the dorso-lumbar vertebral junction 107
Somministrazione intradetrusoriale di tossina botulinica A in pazienti con iperattività detrusoriale e vescica iperattiva dovute a M. di Parkinson ed Atrofia Multisistemica 107
Association of CYP17,GSTP1, and PON1 Polymorphisms With the Risk of Prostate Cancer 107
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). 107
La colposospensione associata a ricostruzione integrale del pavimento pelvico 106
Studio randomizzato multicentrico TVT vs TOT: esperienza a 2 anni 106
Retropubic versus transobturator mid-urethral slings: in a randomised controlled trial pre-operative VLPP may not predict mid-term outcome 106
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 106
Urethral retroresistance pressure e Valsalva leak Point Pressure nella valutazione della funzione uretrale in pazienti affette da incontinenza urinaria da sforzo 105
A Camey II Modified Neobladder: Long-Term Complications And Functional Results. 105
Ruolo della re-turb nei tumori vesciali superficiali ad altro rischio di progressione e recidiva. 104
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 104
Bladder dysfunction in Spinal Cord Injury (SCI) vs Multiple Sclerosis (MS): urodynamic findings. 104
Intravesical resiniferatoxin versus botulinum-A toxin injections in patients with neurogenic detrusor overactivity: a prospective randomized study 104
Long-term follow-up of a randomized trial comparing sequential bacillus Calmette-Guerin and electromotive mitomycin C with Bacillus Calmette-Guerin alone in high risck superfial bladder cancer. 103
Usefulness of antibiotic prophylaxis in invasive urodynamics in fertile and in postmenopausal female subjects. 103
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 103
BOTULINUM A TOXIN REDUCES THE EXPRESSION OF VANILLOID AND CANNABINOID RECEPTORS IN "IN VITRO" PRIMARY HUMAN SMOOTH MUSCLES CELL CULTURES: PRELIMINARY RESULTS 103
Long term follow up of bladder management in spinal cord injury patients: efficacy and tolerability of conventional treatment 102
Totale 14.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.617 0 0 171 389 181 55 83 1.254 61 55 505 863
2022/20237.450 699 949 233 628 591 901 71 408 2.469 36 346 119
2023/20242.638 217 326 118 53 32 41 438 198 456 73 343 343
2024/20255.694 108 813 171 228 833 167 88 466 1.176 343 797 504
2025/202611.671 933 837 549 1.701 1.312 941 1.891 561 1.360 1.133 297 156
2026/20271.129 282 480 367 0 0 0 0 0 0 0 0 0
Totale 44.273